Birdwatch Note
2025-02-25 20:45:40 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Methylene blue is FDA approved to treat a blood disorder called methemoglobinemia. While promising in animal studies, there is currently limited clinical data on methylene blue's efficacy in treating seizures in humans. https://www.goodrx.com/methylene-blue/methylene-blue-uses https://pmc.ncbi.nlm.nih.gov/articles/PMC8513497
Written by F735563C1D6CACAE98B239A5BF3B6B29334E5A32093D655B66C4A4A96408409D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1894478051557188031
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1894488958249164886
- noteId - 1894488958249164886
- participantId -
- noteAuthorParticipantId - F735563C1D6CACAE98B239A5BF3B6B29334E5A32093D655B66C4A4A96408409D Participant Details
- createdAtMillis - 1740516340207
- tweetId - 1894478051557188031
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Methylene blue is FDA approved to treat a blood disorder called methemoglobinemia. While promising in animal studies, there is currently limited clinical data on methylene blue's efficacy in treating seizures in humans. https://www.goodrx.com/methylene-blue/methylene-blue-uses https://pmc.ncbi.nlm.nih.gov/articles/PMC8513497
Note Ratings
| rated at | rated by | |
| 2025-02-26 12:21:56 -0600 | Rating Details | |
| 2025-02-26 11:45:45 -0600 | Rating Details | |
| 2025-02-26 11:41:11 -0600 | Rating Details | |
| 2025-02-26 11:25:19 -0600 | Rating Details | |
| 2025-02-26 11:24:02 -0600 | Rating Details | |
| 2025-02-26 10:55:21 -0600 | Rating Details | |
| 2025-02-26 08:48:20 -0600 | Rating Details | |
| 2025-02-26 08:48:04 -0600 | Rating Details | |
| 2025-02-26 08:13:35 -0600 | Rating Details | |
| 2025-02-26 08:10:21 -0600 | Rating Details | |
| 2025-02-26 06:56:10 -0600 | Rating Details | |
| 2025-02-26 06:00:04 -0600 | Rating Details | |
| 2025-02-26 04:21:30 -0600 | Rating Details | |
| 2025-02-26 04:05:48 -0600 | Rating Details | |
| 2025-02-26 02:46:56 -0600 | Rating Details | |
| 2025-02-26 00:55:57 -0600 | Rating Details | |
| 2025-02-25 23:13:50 -0600 | Rating Details | |
| 2025-02-25 23:05:33 -0600 | Rating Details | |
| 2025-02-25 22:36:30 -0600 | Rating Details | |
| 2025-02-25 22:28:29 -0600 | Rating Details | |
| 2025-02-25 22:25:43 -0600 | Rating Details | |
| 2025-02-25 21:59:56 -0600 | Rating Details | |
| 2025-02-25 21:57:25 -0600 | Rating Details | |
| 2025-02-25 21:35:46 -0600 | Rating Details | |
| 2025-02-25 21:34:25 -0600 | Rating Details | |
| 2025-02-25 21:09:46 -0600 | Rating Details | |
| 2025-02-25 20:33:32 -0600 | Rating Details | |
| 2025-02-25 20:17:19 -0600 | Rating Details | |
| 2025-02-25 20:13:17 -0600 | Rating Details | |
| 2025-02-25 19:37:57 -0600 | Rating Details | |
| 2025-02-25 18:48:16 -0600 | Rating Details | |
| 2025-02-25 17:50:25 -0600 | Rating Details | |
| 2025-02-26 17:48:04 -0600 | Rating Details | |
| 2025-02-26 11:34:20 -0600 | Rating Details | |
| 2025-02-26 08:06:18 -0600 | Rating Details | |
| 2025-02-26 06:07:21 -0600 | Rating Details | |
| 2025-02-26 05:59:57 -0600 | Rating Details | |
| 2025-02-26 03:08:13 -0600 | Rating Details | |
| 2025-02-26 01:55:56 -0600 | Rating Details | |
| 2025-02-25 23:28:23 -0600 | Rating Details | |
| 2025-02-25 22:45:11 -0600 | Rating Details | |
| 2025-02-25 22:21:08 -0600 | Rating Details | |
| 2025-02-25 14:57:37 -0600 | Rating Details | |
| 2025-03-02 22:47:38 -0600 | Rating Details | |
| 2025-02-26 14:13:03 -0600 | Rating Details | |
| 2025-02-26 06:11:22 -0600 | Rating Details | |
| 2025-02-26 04:00:34 -0600 | Rating Details | |
| 2025-02-26 02:32:02 -0600 | Rating Details | |
| 2025-02-26 01:45:17 -0600 | Rating Details | |
| 2025-02-26 00:39:21 -0600 | Rating Details | |
| 2025-02-25 23:13:21 -0600 | Rating Details | |
| 2025-02-25 20:47:53 -0600 | Rating Details | |
| 2025-02-25 20:30:50 -0600 | Rating Details | |
| 2025-02-25 16:37:29 -0600 | Rating Details | |
| 2025-02-25 14:49:22 -0600 | Rating Details |